SSPL WEALTH PVT LTD

Saturday 22 Feb, 2025 12:10 PM

Jio Financial, Zomato to become part of Nifty 50 index Lupin gets EIR from USFDA for New Jersey facility Granules India's board OKs to acquire 100% stake in Senn Chemicals AG Agarwal Industrial bags bitumen supply contract from BPCL Pfizer partners with Mylan for marketing of Ativan and Pacitane One MobiKwik to acquire 3.39% stake in Blostem Fintech Religare Enterprises surges after Burman Family secures majority control Mahindra & Mahindra Ltd leads losers in 'A' group FCS Software Solutions Ltd leads losers in 'B' group DEV IT jumps on bagging order from Rajya Sabha Secretariat Volumes jump at Godrej Industries Ltd counter Consumer goods stocks edge lower Healthcare shares fall Auto stocks edge lower Auto stocks take a hit amid speculation of EV import duty cut

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Pfizer partners with Mylan for marketing of Ativan and Pacitane

21-Feb-25 15:25 Hrs IST

The agreement is for a period of five years and applies within the territory of India.

Mylan has a strong presence in the Central Nervous System (CNS) therapy area, supported by skilled resources that engage with super specialists such as neurologists and psychiatrists. This collaboration with Mylan will enhance the distribution and in-clinic presence of Pfizer's products.

Pfizer is involved in the manufacturing, marketing, trading, and export of pharmaceutical products.

The pharma company's net profit rose 2.8% to Rs 127.60 crore in Q3 FY25 as against Rs 124.11 crore recorded in Q3 FY24. Revenue from operations shed 0.4% year on year to Rs 537.99 crore during the quarter.

Shares of Pfizer shed 0.41% to Rs 4,095.55 on the BSE.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 39051213

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)